talactoferrin alfa has been researched along with Necrotizing Enterocolitis in 2 studies
talactoferrin alfa: recombinant human lactoferrin, an oral drug for treatment of refractory solid tumors; in Phase I trial 5/2006
Excerpt | Relevance | Reference |
---|---|---|
" Talactoferrin alfa (TLf) is a recombinant human Lf shown to protect against sepsis and necrotizing enterocolitis as well as cancer." | 3.80 | Comparison of bioactivities of talactoferrin and lactoferrins from human and bovine milk. ( Du, X; Jiang, R; Lönnerdal, B, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jiang, R | 1 |
Du, X | 1 |
Lönnerdal, B | 1 |
Sherman, MP | 1 |
Adamkin, DH | 1 |
Niklas, V | 1 |
Radmacher, P | 1 |
Sherman, J | 1 |
Wertheimer, F | 1 |
Petrak, K | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Phase 1/2 Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants[NCT00854633] | Phase 1/Phase 2 | 120 participants (Anticipated) | Interventional | 2009-06-30 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for talactoferrin alfa and Necrotizing Enterocolitis
Article | Year |
---|---|
Randomized Controlled Trial of Talactoferrin Oral Solution in Preterm Infants.
Topics: Administration, Oral; Bacteremia; Cross Infection; Double-Blind Method; Enterocolitis, Necrotizing; | 2016 |
1 other study available for talactoferrin alfa and Necrotizing Enterocolitis
Article | Year |
---|---|
Comparison of bioactivities of talactoferrin and lactoferrins from human and bovine milk.
Topics: Animals; Apoptosis; Caco-2 Cells; Cattle; Cell Proliferation; Chemokine CCL20; Colonic Neoplasms; En | 2014 |